• Pharma
  • December 22, 2020
  • 8 views
AstraZeneca Pharma gets DCGI nod to market asthma drug

NEW DELHI: Drug firm AstraZeneca Pharma on Monday said it has received marketing authorisation from Drug Controller General of India for Benralizumab solution, indicated as an add-on maintenance treatment for severe asthma. AstraZeneca Pharma India Ltd has received import…